The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer

55Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The prognostic value of C-reactive protein, compared with ECOG performance status (ECOG-ps), in patients receiving alpha-interferon treatment for advanced renal cancer was assessed in 58 patients. In all, 55 patients died on follow-up. On multivariate analysis with ECOG-ps and C-reactive protein entered as covariates, only C-reactive protein was a significant independent predictor of survival (HR 2.03, 95% Cl 1.09-3.80, P = 0.026). © 2004 Cancer Research UK.

Cite

CITATION STYLE

APA

Bromwich, E., McMillan, D. C., Lamb, G. W. A., Vasey, P. A., & Aitchison, M. (2004). The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer. British Journal of Cancer, 91(7), 1236–1238. https://doi.org/10.1038/sj.bjc.6602152

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free